↓ Skip to main content

Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, January 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#43 of 822)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
twitter
4 tweeters

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization
Published in
Allergy, Asthma & Clinical Immunology, January 2015
DOI 10.1186/1710-1492-11-1
Pubmed ID
Authors

Katinka Ónodi-Nagy, Ágnes Kinyó, Angéla Meszes, Edina Garaczi, Lajos Kemény, Zsuzsanna Bata-Csörgő

Abstract

It hasn't been clearly understood yet whether sensitization to antibiotics, the virus itself or transient loss of drug tolerance due to the virus, is responsible for the development of maculopapular exanthems following amoxicillin intake in patients with infectious mononucleosis. We aimed to examine whether sensitization to penicillin developed among patients with skin rash following amoxicillin treatment within infectious mononucleosis.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 16%
Student > Ph. D. Student 7 14%
Student > Postgraduate 7 14%
Student > Master 6 12%
Other 5 10%
Other 11 22%
Unknown 6 12%
Readers by discipline Count As %
Medicine and Dentistry 32 64%
Immunology and Microbiology 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Agricultural and Biological Sciences 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 2 4%
Unknown 8 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2022.
All research outputs
#996,293
of 21,915,944 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#43
of 822 outputs
Outputs of similar age
#15,598
of 345,654 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#6
of 59 outputs
Altmetric has tracked 21,915,944 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 822 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,654 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.